Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Akiko Mori

Showing results (61-70 of 66) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 66 results.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|February 11, 2018
Novel epigenetic markers for gastric cancer risk stratification in individuals after Helicobacter pylori eradicationMasahiro Maeda, Satoshi Yamashita, Taichi Shimazu, et al.
Bioorganic & Medicinal Chemistry Letters|February 7, 2015
Discovery of novel 2-(alkylmorpholin-4-yl)-6-(3-fluoropyridin-4-yl)-pyrimidin-4(3H)-ones as orally-active GSK-3β inhibitors for Alzheimer's diseaseKenji Fukunaga, Daiki Sakai, Kazutoshi Watanabe, et al.
Surgical Case Reports|December 30, 2017
A long-term survival case treated with conversion surgery following chemotherapy after diagnostic metastasectomy for pancreatic cancer with synchronous liver metastasisMitsuhiro Shimura, Masamichi Mizuma, Hiroki Hayashi, et al.
Bioorganic & Medicinal Chemistry Letters|July 18, 2017
Discovery of novel 2-(4-aryl-2-methylpiperazin-1-yl)-pyrimidin-4-ones as glycogen synthase kinase-3β inhibitorsToshiyuki Kohara, Kazuki Nakayama, Kazutoshi Watanabe, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|December 1, 2024
NKX3.1 Helps Distinguish Hyalinizing Clear Cell Carcinoma From Other Clear Cell Salivary Gland NeoplasmsAiri Sakyo, Eijitsu Ryo, Shogo Nishino, et al.
Bioorganic & Medicinal Chemistry Letters|November 2, 2013
2-(2-Phenylmorpholin-4-yl)pyrimidin-4(3H)-ones; a new class of potent, selective and orally active glycogen synthase kinase-3β inhibitorsKenji Fukunaga, Fumiaki Uehara, Keiichi Aritomo, et al.
Pageof 7

Showing results (61-70 of 66) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 66 results.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|February 11, 2018
Novel epigenetic markers for gastric cancer risk stratification in individuals after Helicobacter pylori eradicationMasahiro Maeda, Satoshi Yamashita, Taichi Shimazu, et al.
Bioorganic & Medicinal Chemistry Letters|February 7, 2015
Discovery of novel 2-(alkylmorpholin-4-yl)-6-(3-fluoropyridin-4-yl)-pyrimidin-4(3H)-ones as orally-active GSK-3β inhibitors for Alzheimer's diseaseKenji Fukunaga, Daiki Sakai, Kazutoshi Watanabe, et al.
Surgical Case Reports|December 30, 2017
A long-term survival case treated with conversion surgery following chemotherapy after diagnostic metastasectomy for pancreatic cancer with synchronous liver metastasisMitsuhiro Shimura, Masamichi Mizuma, Hiroki Hayashi, et al.
Bioorganic & Medicinal Chemistry Letters|July 18, 2017
Discovery of novel 2-(4-aryl-2-methylpiperazin-1-yl)-pyrimidin-4-ones as glycogen synthase kinase-3β inhibitorsToshiyuki Kohara, Kazuki Nakayama, Kazutoshi Watanabe, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|December 1, 2024
NKX3.1 Helps Distinguish Hyalinizing Clear Cell Carcinoma From Other Clear Cell Salivary Gland NeoplasmsAiri Sakyo, Eijitsu Ryo, Shogo Nishino, et al.
Bioorganic & Medicinal Chemistry Letters|November 2, 2013
2-(2-Phenylmorpholin-4-yl)pyrimidin-4(3H)-ones; a new class of potent, selective and orally active glycogen synthase kinase-3β inhibitorsKenji Fukunaga, Fumiaki Uehara, Keiichi Aritomo, et al.
Pageof 7